| Year |
Citation |
Score |
| 2024 |
Zhang X, Shi H, Hendy DA, Bachelder EM, Ainslie KM, Ross TM. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses. Biorxiv : the Preprint Server For Biology. PMID 38464191 DOI: 10.1101/2024.02.27.582355 |
0.596 |
|
| 2024 |
Bayrak CS, Forst C, Jones DR, Gresham D, Pushalkar S, Wu S, Vogel C, Mahal L, Ghedin E, Ross T, García-Sastre A, Zhang B. Patient Subtyping Analysis of Baseline Multi-omic Data Reveals Distinct Pre-immune States Predictive of Vaccination Responses. Biorxiv : the Preprint Server For Biology. PMID 38328256 DOI: 10.1101/2024.01.18.576213 |
0.49 |
|
| 2024 |
Huang Y, Shi H, Forgacs D, Ross TM. Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection. Vaccine. PMID 38296701 DOI: 10.1016/j.vaccine.2023.12.084 |
0.586 |
|
| 2024 |
Rowe T, Davis W, Wentworth DE, Ross T. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells. Journal of Virology. e0149423. PMID 38294251 DOI: 10.1128/jvi.01494-23 |
0.465 |
|
| 2024 |
Ge Y, Cao W, Sun S, Ross TM, Shen Y. The Seasonal Influenza Vaccine Cannot Trigger a Titer Increase Among Some Elderly Individuals. Medrxiv : the Preprint Server For Health Sciences. PMID 38293130 DOI: 10.1101/2024.01.17.24301451 |
0.506 |
|
| 2024 |
Fu H, Pickering H, Rubbi L, Ross TM, Reed EF, Pellegrini M. Longitudinal analysis of influenza vaccination implicates regulation of RIG-I signaling by DNA methylation. Scientific Reports. 14: 1455. PMID 38228690 DOI: 10.1038/s41598-024-51665-9 |
0.51 |
|
| 2024 |
Uno N, Ross TM. Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses. Scientific Reports. 14: 1440. PMID 38228649 DOI: 10.1038/s41598-023-51024-0 |
0.579 |
|
| 2024 |
Tong X, Deng Y, Cizmeci D, Fontana L, Carlock MA, Hanley HB, McNamara RP, Lingwood D, Ross TM, Alter G. Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination. Journal of Immunology (Baltimore, Md. : 1950). PMID 37975667 DOI: 10.4049/jimmunol.2200956 |
0.564 |
|
| 2023 |
Hendy DA, Pena ES, Ontiveros-Padilla L, Dixon TA, Middleton DD, Williamson GL, Lukesh NR, Simpson SR, Stiepel RT, Islam MJ, Carlock MA, Ross TM, Bachelder EM, Ainslie KM. Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations. Bioengineering & Translational Medicine. 9: e10634. PMID 38435811 DOI: 10.1002/btm2.10634 |
0.562 |
|
| 2023 |
Nuñez IA, Jang H, Huang Y, Kelvin A, Ross TM. Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1. Frontiers in Veterinary Science. 10: 1286758. PMID 38170075 DOI: 10.3389/fvets.2023.1286758 |
0.547 |
|
| 2023 |
Uno N, Ross TM. Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responses. Cell Host & Microbe. 31: 1772-1773. PMID 37944489 DOI: 10.1016/j.chom.2023.10.014 |
0.445 |
|
| 2023 |
Silva-Moraes V, Souquette A, Sautto GA, Paciello I, Antonelli G, Andreano E, Rappuoli R, Teixeira-Carvalho A, Ross TM. Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity. Immunohorizons. 7: 635-651. PMID 37819998 DOI: 10.4049/immunohorizons.2300041 |
0.455 |
|
| 2023 |
Carlock MA, Ross TM. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages. Scientific Reports. 13: 15911. PMID 37741893 DOI: 10.1038/s41598-023-43003-2 |
0.576 |
|
| 2023 |
Sung MH, Billings W, Carlock MA, Hanley HB, Bahl J, Handel A, Ross TM, Shen Y. Assessment of humoral immune responses to repeated influenza vaccination in a multiyear cohort: a five-year follow-up. The Journal of Infectious Diseases. PMID 37624957 DOI: 10.1093/infdis/jiad319 |
0.517 |
|
| 2023 |
Hendy DA, Lifshits LM, Batty CJ, Carlock MA, Ross TM, Mousa JJ, Bachelder EM, Ainslie KM. Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability. Molecular Pharmaceutics. PMID 37603310 DOI: 10.1021/acs.molpharmaceut.3c00424 |
0.54 |
|
| 2023 |
Honda-Okubo Y, Li L, André G, Leong KH, Howerth EW, Bebin-Blackwell AG, Ross TM, Petrovsky N. An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge. Vaccine. PMID 37355452 DOI: 10.1016/j.vaccine.2023.06.063 |
0.495 |
|
| 2023 |
Dzimianski JV, Han J, Sautto GA, O'Rourke SM, Cruz JM, Pierce SR, Ecker JW, Carlock MA, Nagashima KA, Mousa JJ, Ross TM, Ward AB, DuBois RM. Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications Biology. 6: 454. PMID 37185989 DOI: 10.1038/s42003-023-04793-3 |
0.495 |
|
| 2023 |
Jenkins MM, Phan Tran D, Flores EA, Kupferwasser D, Pickering H, Zheng Y, Gjertson DW, Ross TM, Schaenman JM, Miller LG, Yeaman MR, Reed EF. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants. Frontiers in Immunology. 14: 1139915. PMID 37153624 DOI: 10.3389/fimmu.2023.1139915 |
0.433 |
|
| 2023 |
Ontiveros-Padilla L, Batty CJ, Hendy DA, Pena ES, Roque JA, Stiepel RT, Carlock MA, Simpson SR, Ross TM, Abraham SN, Staats HF, Bachelder EM, Ainslie KM. Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG. Frontiers in Immunology. 14: 1103765. PMID 37033992 DOI: 10.3389/fimmu.2023.1103765 |
0.54 |
|
| 2023 |
Criado MF, Kassa A, Bertran K, Kwon JH, Sá E Silva M, Killmaster L, Ross TM, Mebatsion T, Swayne DE. Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses. Vaccine. PMID 37012117 DOI: 10.1016/j.vaccine.2023.03.055 |
0.585 |
|
| 2023 |
Boudreau CM, Burke JS, Roederer AL, Gorman MJ, Mundle S, Lingwood D, Delagrave S, Sridhar S, Ross TM, Kleanthous H, Alter G. Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. Cell Reports. Medicine. 100975. PMID 36921600 DOI: 10.1016/j.xcrm.2023.100975 |
0.501 |
|
| 2023 |
Gandhapudi SK, Shi H, Ward MR, Bush JP, Avdiushko M, Sundarapandiyan K, Wood LV, Dorrani M, Fatima A, Dervan J, Bedu-Addo F, Conn G, Ross TM, Woodward JG. Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses. 15. PMID 36851646 DOI: 10.3390/v15020432 |
0.484 |
|
| 2023 |
Nagashima K, Abbadi N, Vyas V, Roegner A, Ross TM, Mousa JJ. Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses. 15. PMID 36851561 DOI: 10.3390/v15020347 |
0.451 |
|
| 2023 |
Batty CJ, Lifshits LM, Hendy DA, Eckshtain-Levi M, Ontiveros-Padilla LA, Carlock MA, Ross TM, Bachelder EM, Ainslie KM. Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine. The Aaps Journal. 25: 22. PMID 36720729 DOI: 10.1208/s12248-023-00786-6 |
0.575 |
|
| 2023 |
Rodrick TC, Siu Y, Carlock MA, Ross TM, Jones DR. Urine Metabolome Dynamics Discriminate Influenza Vaccination Response. Viruses. 15. PMID 36680282 DOI: 10.3390/v15010242 |
0.507 |
|
| 2023 |
Ge P, Ross TM. Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses. Viruses. 15. PMID 36680243 DOI: 10.3390/v15010203 |
0.604 |
|
| 2023 |
Skarlupka AL, Zhang X, Blas-Machado U, Sumner SF, Ross TM. Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase. Viruses. 15. PMID 36680224 DOI: 10.3390/v15010184 |
0.541 |
|
| 2022 |
Batty CJ, Amouzougan EA, A Carlock M, Ross TM, Bachelder EM, Ainslie KM. Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutinin. International Journal of Pharmaceutics. 630: 122429. PMID 36436743 DOI: 10.1016/j.ijpharm.2022.122429 |
0.481 |
|
| 2022 |
Wu S, Pushalkar S, Maity S, Pressler M, Rendleman J, Vitrinel B, Carlock M, Ross T, Choi H, Vogel C. Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study. Viruses. 14. PMID 36366577 DOI: 10.3390/v14112479 |
0.479 |
|
| 2022 |
Forst CV, Chung M, Hockman M, Lashua L, Adney E, Hickey A, Carlock M, Ross T, Ghedin E, Gresham D. Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes. Viruses. 14. PMID 36366544 DOI: 10.3390/v14112446 |
0.516 |
|
| 2022 |
Tan S, Moise L, Pearce DS, Kyriakis CS, Gutiérrez AH, Ross TM, Bahl J, De Groot AS. H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans. Influenza and Other Respiratory Viruses. PMID 36285342 DOI: 10.1111/irv.13058 |
0.509 |
|
| 2022 |
Ross TM, Gokanapudi N, Ge P, Shi H, Richardson RA, Pierce SR, Sanchez P, Ullah S, De Luca E, Sautto GA. Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens. Vaccines. 10. PMID 36016202 DOI: 10.3390/vaccines10081315 |
0.508 |
|
| 2022 |
Bellusci L, Grubbs G, Zahra FT, Forgacs D, Golding H, Ross TM, Khurana S. Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination. Nature Communications. 13: 4617. PMID 35941152 DOI: 10.1038/s41467-022-32298-w |
0.48 |
|
| 2022 |
Abbadi N, Nagashima K, Pena-Briseno A, Ross TM, Mousa JJ. Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies. Journal of Virology. e0089622. PMID 35916534 DOI: 10.1128/jvi.00896-22 |
0.482 |
|
| 2022 |
AboulFotouh K, Uno N, Xu H, Moon C, Sahakijpijarn S, Christensen DJ, Davenport GJ, Cano C, Ross TM, Williams Iii RO, Cui Z. Formulation of Dry Powders of Vaccines Containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine. International Journal of Pharmaceutics. 122021. PMID 35842082 DOI: 10.1016/j.ijpharm.2022.122021 |
0.501 |
|
| 2022 |
Qin R, Meng G, Pushalkar S, Carlock MA, Ross TM, Vogel C, Mahal LK. Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway. Journal of Proteome Research. PMID 35757850 DOI: 10.1021/acs.jproteome.2c00251 |
0.53 |
|
| 2022 |
Eckshtain-Levi M, Batty CJ, Lifshits LM, McCammitt B, Moore KM, Amouzougan EA, Stiepel RT, Duggan E, Ross TM, Bachelder EM, Ainslie KM. Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine. Acs Applied Materials & Interfaces. 14: 28548-28558. PMID 35704854 DOI: 10.1021/acsami.2c04671 |
0.418 |
|
| 2022 |
Moise L, Meyers LM, Jang H, Grizotte-Lake M, Boyle CM, McGonnigal B, Ge P, Ross TM, De Groot AS. Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice. Human Vaccines & Immunotherapeutics. 2082191. PMID 35704783 DOI: 10.1080/21645515.2022.2082191 |
0.487 |
|
| 2022 |
Nagashima K, Dzimianski JV, Han J, Abbadi N, Gingerich AD, Royer F, O'Rourke S, Sautto GA, Ross TM, Ward AB, DuBois RM, Mousa JJ. The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines. Journal of Immunology (Baltimore, Md. : 1950). PMID 35697384 DOI: 10.4049/jimmunol.2101171 |
0.455 |
|
| 2022 |
Hernandez AM, Mossman JA, Toapanta FR, Previte DM, Ross TM, Nau GJ. Altered transcriptional responses in the lungs of aged mice after influenza infection. Immunity & Ageing : I & A. 19: 27. PMID 35650631 DOI: 10.1186/s12979-022-00286-9 |
0.746 |
|
| 2022 |
Forgacs D, Silva-Moraes V, Sautto GA, Hanley HB, Gattiker JL, Jefferson AM, Kolhe R, Ross TM. The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination. Vaccines. 10. PMID 35632452 DOI: 10.3390/vaccines10050696 |
0.388 |
|
| 2022 |
Batty CJ, Gallovic MD, Williams J, Ross TM, Bachelder EM, Ainslie KM. Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine. International Journal of Pharmaceutics. 622: 121839. PMID 35623484 DOI: 10.1016/j.ijpharm.2022.121839 |
0.537 |
|
| 2022 |
Simon V, Kota V, Bloomquist RF, Hanley HB, Forgacs D, Pahwa S, Pallikkuth S, Miller LG, Schaenman J, Yeaman MR, Manthei D, Wolf J, Gaur AH, Estepp JH, Srivastava K, ... ... Ross TM, et al. PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2. Msphere. e0017922. PMID 35586986 DOI: 10.1128/msphere.00179-22 |
0.441 |
|
| 2022 |
Wu S, Ross TM, Carlock MA, Ghedin E, Choi H, Vogel C. Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine. Molecular Systems Biology. 18: e10724. PMID 35514207 DOI: 10.15252/msb.202110724 |
0.486 |
|
| 2022 |
Ullah S, Ross TM. Next generation live-attenuated influenza vaccine platforms. Expert Review of Vaccines. 1-14. PMID 35502639 DOI: 10.1080/14760584.2022.2072301 |
0.577 |
|
| 2022 |
Varma DM, Batty CJ, Stiepel RT, Graham-Gurysh EG, Roque JA, Pena ES, Hasan Zahid MS, Qiu K, Anselmo A, Hill DB, Ross TM, Bachelder EM, Ainslie KM. Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza Vaccine. Acs Biomaterials Science & Engineering. PMID 35353486 DOI: 10.1021/acsbiomaterials.2c00015 |
0.529 |
|
| 2022 |
Forgacs D, Moraes VS, Hanley HB, Gattiker JL, Jefferson AM, Ross TM. The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination. Biorxiv : the Preprint Server For Biology. PMID 35313572 DOI: 10.1101/2022.03.16.484099 |
0.399 |
|
| 2022 |
Allen JD, Ross TM. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019. Journal of Virology. e0165221. PMID 35289635 DOI: 10.1128/jvi.01652-21 |
0.545 |
|
| 2022 |
Chen X, Sun HY, Lee CY, Rostad CA, Trost J, Abreu RB, Carlock MA, Wilson JR, Gansebom S, Ross TM, Steinhauer DA, Anderson EJ, Anderson LJ. Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination. Virology. 569: 44-55. PMID 35255298 DOI: 10.1016/j.virol.2022.02.004 |
0.497 |
|
| 2022 |
Corallo KL, Lyle SM, Carlock MA, Ross TM, Ehrlich KB. Emotional Distress, Targeted Rejection, and Antibody Production Following Influenza Vaccination in Adolescence. Psychosomatic Medicine. PMID 35100185 DOI: 10.1097/PSY.0000000000001054 |
0.418 |
|
| 2021 |
Huang Y, Skarlupka AL, Jang H, Blas-Machado U, Holladay N, Hogan RJ, Ross TM. SARS-CoV-2 and Influenza A virus Co-infections in Ferrets. Journal of Virology. JVI0179121. PMID 34936487 DOI: 10.1128/JVI.01791-21 |
0.509 |
|
| 2021 |
Tang J, Grubbs G, Lee Y, Huang C, Ravichandran S, Forgacs D, Golding H, Ross TM, Khurana S. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex. Ebiomedicine. 74: 103748. PMID 34902788 DOI: 10.1016/j.ebiom.2021.103748 |
0.386 |
|
| 2021 |
Spencer S, Chung JR, Belongia EA, Sundaram M, Meece J, Coleman LA, Zimmerman RK, Nowalk MP, Moehling Geffel K, Ross T, Carter CE, Shay D, Levine M, Liepkalns J, Kim JH, et al. Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. Influenza and Other Respiratory Viruses. PMID 34859584 DOI: 10.1111/irv.12933 |
0.468 |
|
| 2021 |
Nuñez IA, Huang Y, Ross TM. Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections. Pathogens (Basel, Switzerland). 10. PMID 34832509 DOI: 10.3390/pathogens10111352 |
0.597 |
|
| 2021 |
Jang H, Ross TM. Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines. Plos One. 16: e0258453. PMID 34679115 DOI: 10.1371/journal.pone.0258453 |
0.575 |
|
| 2021 |
Forgacs D, Jang H, Abreu RB, Hanley HB, Gattiker JL, Jefferson AM, Ross TM. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in Immunology. 12: 728021. PMID 34646267 DOI: 10.3389/fimmu.2021.728021 |
0.523 |
|
| 2021 |
Kirchenbaum GA, Sautto GA, Richardson RA, Ecker JW, Ross TM. A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus. Journal of Virology. JVI0237920. PMID 34523961 DOI: 10.1128/JVI.02379-20 |
0.508 |
|
| 2021 |
Allen JD, Ross TM. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses. Frontiers in Immunology. 12: 707339. PMID 34475872 DOI: 10.3389/fimmu.2021.707339 |
0.607 |
|
| 2021 |
Li L, Honda-Okubo Y, Huang Y, Jang H, Carlock MA, Baldwin J, Piplani S, Bebin-Blackwell AG, Forgacs D, Sakamoto K, Stella A, Turville S, Chataway T, Colella A, Triccas J, ... Ross TM, et al. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Vaccine. PMID 34420786 DOI: 10.1016/j.vaccine.2021.07.087 |
0.547 |
|
| 2021 |
Skarlupka AL, Ross TM. Inherent Serum Inhibition of Influenza Virus Neuraminidases. Frontiers in Veterinary Science. 8: 677693. PMID 34409085 DOI: 10.3389/fvets.2021.677693 |
0.533 |
|
| 2021 |
Huang Y, França MS, Allen JD, Shi H, Ross TM. Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection. Vaccines. 9. PMID 34358209 DOI: 10.3390/vaccines9070793 |
0.612 |
|
| 2021 |
Abreu RB, Kirchenbaum GA, Sautto GA, Clutter EF, Ross TM. Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination. Plos One. 16: e0254421. PMID 34351920 DOI: 10.1371/journal.pone.0254421 |
0.564 |
|
| 2021 |
Jung J, Mundle ST, Ustyugova IV, Horton AP, Boutz DR, Pougatcheva S, Prabakaran P, McDaniel JR, King GR, Park D, Person MD, Ye C, Tan B, Tanno Y, Kim JE, ... ... Ross TM, et al. Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans. The Journal of Clinical Investigation. 131. PMID 34196304 DOI: 10.1172/JCI148763 |
0.541 |
|
| 2021 |
Sarr D, Gingerich AD, Asthiwi NM, Almutairi F, Sautto GA, Ecker J, Nagy T, Kilgore MB, Chandler JD, Ross TM, Tripp RA, Rada B. Dual oxidase 1 promotes antiviral innate immunity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34168077 DOI: 10.1073/pnas.2017130118 |
0.381 |
|
| 2021 |
Skarlupka AL, Bebin-Blackwell AG, Sumner SF, Ross TM. Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains. Journal of Virology. JVI0075921. PMID 34160258 DOI: 10.1128/JVI.00759-21 |
0.583 |
|
| 2021 |
Beau Reneer Z, Abreu RB, Jamal US, Corn MR, Paugh JL, Ross TM. Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans. Vaccine. PMID 34127298 DOI: 10.1016/j.vaccine.2021.05.064 |
0.522 |
|
| 2021 |
Forgacs D, Jang H, Abreu RB, Hanley HB, Gattiker JL, Jefferson AM, Ross TM. Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically nave and pre-immune humans. Biorxiv : the Preprint Server For Biology. PMID 34100015 DOI: 10.1101/2021.05.29.445137 |
0.521 |
|
| 2021 |
Sautto GA, Ecker JW, Ross TM. An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus. Journal of Virology. PMID 33853960 DOI: 10.1128/JVI.02421-20 |
0.504 |
|
| 2021 |
Ge P, Ross TM. Evolution and biological significance of A(H1N1) pdm09 influenza virus hemagglutinin glycosylation. Expert Review of Vaccines. PMID 33756084 DOI: 10.1080/14760584.2021.1908135 |
0.451 |
|
| 2021 |
Sung MH, Shen Y, Handel A, Bahl J, Ross TM. Longitudinal Assessment of Immune Responses to Repeated Annual Influenza Vaccination in a Human Cohort of Adults and Teenagers. Frontiers in Immunology. 12: 642791. PMID 33746985 DOI: 10.3389/fimmu.2021.642791 |
0.45 |
|
| 2021 |
Jang H, Ross TM. Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles. Plos One. 16: e0246613. PMID 33735274 DOI: 10.1371/journal.pone.0246613 |
0.409 |
|
| 2021 |
Bertran K, Kassa A, Criado MF, Nuñez IA, Lee DH, Killmaster L, Sá E Silva M, Ross TM, Mebatsion T, Pritchard N, Swayne DE. Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses. Vaccine. 39: 1933-1942. PMID 33715903 DOI: 10.1016/j.vaccine.2021.02.075 |
0.507 |
|
| 2021 |
Reneer ZB, Skarlupka AL, Jamieson PJ, Ross TM. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses. Msphere. 6. PMID 33692193 DOI: 10.1128/mSphere.00052-21 |
0.569 |
|
| 2021 |
Allen JD, Ross TM. Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses. Scientific Reports. 11: 4554. PMID 33654128 DOI: 10.1038/s41598-020-79590-7 |
0.585 |
|
| 2021 |
Forgacs D, Abreu RB, Sautto GA, Kirchenbaum GA, Drabek E, Williamson KS, Kim D, Emerling DE, Ross TM. Convergent antibody evolution and clonotype expansion following influenza virus vaccination. Plos One. 16: e0247253. PMID 33617543 DOI: 10.1371/journal.pone.0247253 |
0.546 |
|
| 2021 |
Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM, Cameron MJ, Friemann MB, Neumann G, Kawaoka Y, Kelvin AA, Ross TM, Schultz-Cherry S, Mastro TD, Priddy FH, et al. Development and deployment of COVID-19 vaccines for those most vulnerable. Science Translational Medicine. 13. PMID 33536277 DOI: 10.1126/scitranslmed.abd1525 |
0.472 |
|
| 2021 |
Shen H, Forgacs D, Chapla D, Moremen KW, Wells L, Hamer SA, Tompkins SM, Ross TM, Rouphael N, Edupuganti S, Collins MH, Tarleton RL. A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses. Medrxiv : the Preprint Server For Health Sciences. PMID 33532799 DOI: 10.1101/2021.01.20.21249279 |
0.377 |
|
| 2021 |
Penkert RR, Patel N, Webby RJ, Ross TM, Hurwitz JL. Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults. Vaccines. 9. PMID 33498232 DOI: 10.3390/vaccines9020068 |
0.555 |
|
| 2020 |
Uno N, Ross TM. A Universal Dengue Vaccine Elicits Neutralizing Antibodies Against Strains from All Four Dengue Serotypes. Journal of Virology. PMID 33208445 DOI: 10.1128/JVI.00658-20 |
0.5 |
|
| 2020 |
Reneer ZB, Jamieson PJ, Skarlupka AL, Huang Y, Ross TM. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges. Journal of Virology. PMID 33115871 DOI: 10.1128/JVI.01526-20 |
0.531 |
|
| 2020 |
Heindel DW, Koppolu S, Zhang Y, Kasper B, Meche L, Vaiana CA, Bissel SJ, Carter CE, Kelvin AA, Elaish M, Lopez-Orozco J, Zhang B, Zhou B, Chou TW, Lashua L, ... ... Ross TM, et al. Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity. Proceedings of the National Academy of Sciences of the United States of America. PMID 33046650 DOI: 10.1073/pnas.2008203117 |
0.415 |
|
| 2020 |
Chen S, Kasper B, Zhang B, Lashua LP, Ross TM, Ghedin E, Mahal LK. Age-dependent glycomic response to the 2009 pandemic H1N1 influenza virus and its association with disease severity. Journal of Proteome Research. PMID 32981324 DOI: 10.1021/acs.jproteome.0c00455 |
0.346 |
|
| 2020 |
Moise L, Ross TM, Hoft DF, Martin WD, De Groot AS. "Mindful" development of rapid, safe and effective COVID-19 vaccines. Expert Review of Vaccines. PMID 32962468 DOI: 10.1080/14760584.2020.1825946 |
0.513 |
|
| 2020 |
Ecker JW, Kirchenbaum GA, Pierce SR, Skarlupka AL, Abreu RB, Cooper RE, Taylor-Mulneix D, Ross TM, Sautto GA. High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines. Vaccines. 8. PMID 32825605 DOI: 10.3390/Vaccines8030462 |
0.568 |
|
| 2020 |
Skarlupka AL, Handel A, Ross TM. Dataset of antigenic distance measures, hemagglutination inhibition, viral lung titers, and weight loss in mice and ferrets when exposed to HA-based vaccination or sub-lethal A(H1) influenza infection. Data in Brief. 32: 106118. PMID 32793786 DOI: 10.1016/J.Dib.2020.106118 |
0.555 |
|
| 2020 |
Jang H, Meyers LM, Boyle C, De Groot AS, Moise L, Ross TM. Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge. Human Vaccines & Immunotherapeutics. 1-9. PMID 32783766 DOI: 10.1080/21645515.2020.1793711 |
0.591 |
|
| 2020 |
Skarlupka AL, Handel A, Ross TM. Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools. Vaccine. PMID 32682618 DOI: 10.1016/J.Vaccine.2020.06.042 |
0.592 |
|
| 2020 |
Abreu RB, Clutter EF, Attari S, Sautto GA, Ross TM. IgA Responses Following Recurrent Influenza Virus Vaccination. Frontiers in Immunology. 11: 902. PMID 32508822 DOI: 10.3389/Fimmu.2020.00902 |
0.646 |
|
| 2020 |
De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, Hoft DF, Ross TM, Noe AR, Takahashi Y, Kotraiah V, Silk SE, Nielsen CM, Minassian AM, Ashfield R, et al. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology. 11: 442. PMID 32318055 DOI: 10.3389/Fimmu.2020.00442 |
0.58 |
|
| 2020 |
Skarlupka AL, Ross TM. Immune Imprinting in the Influenza Ferret Model. Vaccines. 8. PMID 32276530 DOI: 10.3390/Vaccines8020173 |
0.643 |
|
| 2020 |
Skarlupka AL, Reneer ZB, Abreu RB, Ross TM, Sautto GA. An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses. Journal of Virology. PMID 31996430 DOI: 10.1128/Jvi.02061-19 |
0.536 |
|
| 2019 |
Huang Y, Owino SO, Crevar CJ, Carter DM, Ross TM. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies. Journal of Virology. PMID 31852790 DOI: 10.1128/Jvi.01432-19 |
0.618 |
|
| 2019 |
Qiu Y, Stegalkina S, Zhang J, Boudanova E, Park A, Zhou Y, Prabakaran P, Pougatcheva S, Ustyugova IV, Vogel TU, Mundle ST, Oomen R, Delagrave S, Ross TM, Kleanthous H, et al. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth. Journal of Virology. PMID 31826999 DOI: 10.1128/JVI.01035-19 |
0.578 |
|
| 2019 |
Sautto GA, Kirchenbaum GA, Abreu RB, Ecker JW, Pierce SR, Kleanthous H, Ross TM. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). PMID 31811019 DOI: 10.4049/Jimmunol.1900379 |
0.515 |
|
| 2019 |
Abreu RB, Kirchenbaum GA, Clutter EF, Sautto GA, Ross TM. Pre-existing subtype immunodominance shapes memory B cell recall response to influenza vaccination. Jci Insight. PMID 31794433 DOI: 10.1172/Jci.Insight.132155 |
0.628 |
|
| 2019 |
Nuñez IA, Ross TM. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses. Vaccine. PMID 31733946 DOI: 10.1016/J.Vaccine.2019.10.097 |
0.559 |
|
| 2019 |
Sautto GA, Ross TM. Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity. Veterinaria Italiana. 55: 195-201. PMID 31599544 DOI: 10.12834/Vetit.1944.10352.1 |
0.619 |
|
| 2019 |
Bissel SJ, Carter CE, Wang G, Johnson SK, Lashua LP, Kelvin A, Wiley CA, Ghedin E, Ross TM. Age-related pathology associated with H1N1 A/California/07/2009 influenza virus infection. The American Journal of Pathology. PMID 31585069 DOI: 10.1016/J.Ajpath.2019.08.017 |
0.435 |
|
| 2019 |
Jang H, Ross TM. Pre-existing influenza specific immunity and vaccine effectiveness. Expert Review of Vaccines. PMID 31575308 DOI: 10.1080/14760584.2019.1675519 |
0.605 |
|
| 2019 |
Francis ME, McNeil M, Dawe NJ, Foley MK, King ML, Ross TM, Kelvin AA. Historical H1N1 Influenza Virus Imprinting Increases Vaccine Protection by Influencing the Activity and Sustained Production of Antibodies Elicited at Vaccination in Ferrets. Vaccines. 7. PMID 31569351 DOI: 10.3390/Vaccines7040133 |
0.675 |
|
| 2019 |
Bar-Peled Y, Huang J, Nuñez IA, Pierce SR, Ecker JW, Ross TM, Mousa JJ. Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine. Vaccine. PMID 31481254 DOI: 10.1016/J.Vaccine.2019.08.062 |
0.548 |
|
| 2019 |
Skarlupka AL, Owino SO, Suzuki-Williams LP, Crevar CJ, Carter DM, Ross TM. Computationally Optimized Broadly Reactive Vaccine Based Upon Swine H1N1 Influenza Hemagglutinin Sequences Protects against both Swine and Human Isolated Viruses. Human Vaccines & Immunotherapeutics. PMID 31448974 DOI: 10.1080/21645515.2019.1653743 |
0.603 |
|
| 2019 |
Ross TM, DiNapoli J, Giel-Moloney M, Bloom CE, Bertran K, Balzli C, Strugnell T, Oomen RP, Sá E Silva M, Mebatsion T, Bublot M, Swayne DE, Kleanthous H. Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376]. Vaccine. PMID 31383487 DOI: 10.1016/J.Vaccine.2019.07.058 |
0.512 |
|
| 2019 |
Carlock MA, Ingram JG, Clutter EF, Cecil NC, Ramgopal M, Zimmerman RK, Kleanthous H, Ross TM, Warren W. Impact of age and pre-existing influenza on the induction of human antibody responses against influenza B viruses. Human Vaccines & Immunotherapeutics. PMID 31291153 DOI: 10.1080/21645515.2019.1642056 |
0.636 |
|
| 2019 |
Arévalo MT, Huang Y, Jones CA, Ross TM. Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice. Plos Neglected Tropical Diseases. 13: e0007316. PMID 31026260 DOI: 10.1371/Journal.Pntd.0007316 |
0.612 |
|
| 2019 |
Ross TM, DiNapoli J, Giel-Moloney M, Bloom CE, Bertran K, Balzli C, Strugnell T, Sá E Silva M, Mebatsion T, Bublot M, Swayne DE, Kleanthous H. A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains. Vaccine. PMID 30905528 DOI: 10.1016/J.Vaccine.2019.03.018 |
0.657 |
|
| 2019 |
Nuñez IA, Ross TM. A review of H5Nx avian influenza viruses. Therapeutic Advances in Vaccines and Immunotherapy. 7: 2515135518821625. PMID 30834359 DOI: 10.1177/2515135518821625 |
0.442 |
|
| 2019 |
Ross TM. Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins. The Journal of Infectious Diseases. PMID 30715379 DOI: 10.1093/Infdis/Jiz004 |
0.64 |
|
| 2019 |
Reneer ZB, Ross TM. H2 influenza viruses: designing vaccines against future H2 pandemics. Biochemical Society Transactions. PMID 30647144 DOI: 10.1042/Bst20180602 |
0.541 |
|
| 2018 |
Sautto GA, Kirchenbaum GA, Ecker JW, Bebin-Blackwell AG, Pierce SR, Ross TM. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens. Immunohorizons. 2: 226-237. PMID 31022693 DOI: 10.4049/immunohorizons.1800044 |
0.575 |
|
| 2018 |
Allen JD, Ray S, Ross TM. Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses. Plos One. 13: e0210043. PMID 30589902 DOI: 10.1371/Journal.Pone.0210043 |
0.574 |
|
| 2018 |
Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM. Elicitation of protective antibodies against 20 years of future H3N2 co-ciruculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses. Journal of Virology. PMID 30429350 DOI: 10.1128/Jvi.00946-18 |
0.652 |
|
| 2018 |
Uno N, Ross TM. Dengue virus and the host innate immune response. Emerging Microbes & Infections. 7: 167. PMID 30301880 DOI: 10.1038/s41426-018-0168-0 |
0.439 |
|
| 2018 |
Allen JD, Ray S, Ross TM. Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses. Plos One. 13: e0204284. PMID 30265682 DOI: 10.1371/journal.pone.0204284 |
0.562 |
|
| 2018 |
Darricarrère N, Pougatcheva S, Duan X, Rudicell RS, Chou TH, DiNapoli J, Ross TM, Alefantis T, Vogel TU, Kleanthous H, Wei CJ, Nabel GJ. Development of a Pan-H1 Influenza Vaccine. Journal of Virology. PMID 30185594 DOI: 10.1128/Jvi.01349-18 |
0.618 |
|
| 2018 |
Moise L, Girard B, Boyle C, Kurt Yilmaz N, Jang H, Schiffer C, Ross T, Martin WD, De Groot AS. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response. Human Vaccines & Immunotherapeutics. PMID 30015562 DOI: 10.1080/21645515.2018.1495303 |
0.6 |
|
| 2018 |
Kityo C, Makamdop KN, Rothenberger M, Chipman JG, Hoskuldsson T, Beilman GJ, Grzywacz B, Mugyenyi P, Ssali F, Akondy RS, Anderson J, Schmidt TE, Reimann T, Callisto SP, Schoephoerster J, ... ... Ross TM, et al. Lymphoid tissue fibrosis is associated with impaired vaccine responses. The Journal of Clinical Investigation. PMID 29781814 DOI: 10.1172/Jci97377 |
0.537 |
|
| 2018 |
Allen JD, Ross TM. H3N2 Influenza Viruses in Humans: Viral Mechanisms, Evolution, and Evaluation. Human Vaccines & Immunotherapeutics. 0. PMID 29641358 DOI: 10.1080/21645515.2018.1462639 |
0.546 |
|
| 2018 |
Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virology Journal. 15: 17. PMID 29370862 DOI: 10.1186/S12985-017-0918-Y |
0.651 |
|
| 2018 |
Abreu R, Ross TM. Influenza – A new pathogen every year Current Opinion in Systems Biology. 12: 12-21. DOI: 10.1016/J.Coisb.2018.08.011 |
0.58 |
|
| 2017 |
Moehling KK, Nowalk MP, Lin CJ, Bertolet M, Ross TM, Carter CE, Susick M, Saul SG, Kaynar AM, Bromberger JT, Zimmerman RK. The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age. Human Vaccines & Immunotherapeutics. 1-7. PMID 29172948 DOI: 10.1080/21645515.2017.1405883 |
0.542 |
|
| 2017 |
Nuñez IA, Carlock MA, Allen JD, Owino SO, Moehling KK, Nowalk P, Susick M, Diagle K, Sweeney K, Mundle S, Vogel TU, Delagrave S, Ramgopal M, Zimmerman RK, Kleanthous H, ... Ross TM, et al. Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. Plos One. 12: e0185666. PMID 29091724 DOI: 10.1371/Journal.Pone.0185666 |
0.63 |
|
| 2017 |
Kirchenbaum GA, Allen JD, Layman TS, Sautto GA, Ross TM. Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin. Journal of Immunology (Baltimore, Md. : 1950). PMID 29079697 DOI: 10.4049/Jimmunol.1701174 |
0.57 |
|
| 2017 |
Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM, Alefantis T, DiNapoli J, Kleanthous H, Ross TM. COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants. Journal of Virology. PMID 28978710 DOI: 10.1128/Jvi.01581-17 |
0.638 |
|
| 2017 |
Carter DM, Darby CA, Johnson SK, Carlock MA, Kirchenbaum GA, DiNapoli J, Kleanthous H, Ross TM. Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses. Journal of Virology. PMID 28978709 DOI: 10.1128/Jvi.01283-17 |
0.675 |
|
| 2017 |
Keef E, Zhang LA, Swigon D, Urbano A, Ermentrout GB, Matuszewski M, Toapanta FR, Ross TM, Parker RS, Clermont G. Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity. Journal of Virology. PMID 28904202 DOI: 10.1128/Jvi.00395-17 |
0.761 |
|
| 2017 |
Allen JD, Owino SO, Carter DM, Crevar CJ, Reese VA, Fox CB, Coler RN, Reed SG, Baldwin SL, Ross TM. Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines. Vaccine. PMID 28789850 DOI: 10.1016/J.Vaccine.2017.07.107 |
0.637 |
|
| 2017 |
Platt JL, Silva I, Balin SJ, Lefferts AR, Farkash E, Ross TM, Carroll MC, Cascalho M. C3d regulates immune checkpoint blockade and enhances antitumor immunity. Jci Insight. 2. PMID 28469081 DOI: 10.1172/Jci.Insight.90201 |
0.313 |
|
| 2017 |
Kirchenbaum GA, Ross TM. Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (Mustela putorius furo). Journal of Immunology Research. 2017: 5874572. PMID 28286781 DOI: 10.1155/2017/5874572 |
0.327 |
|
| 2016 |
Ross TM. Commentary on 'Dissecting the hemagglutinin head and stalk specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination'. Npj Vaccines. 1: 16004. PMID 29263850 DOI: 10.1038/npjvaccines.2016.4 |
0.492 |
|
| 2016 |
Lee J, Boutz DR, Chromikova V, Joyce MG, Vollmers C, Leung K, Horton AP, DeKosky BJ, Lee CH, Lavinder JJ, Murrin EM, Chrysostomou C, Hoi KH, Tsybovsky Y, Thomas PV, ... ... Ross TM, et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nature Medicine. PMID 27820605 DOI: 10.1038/Nm.4224 |
0.618 |
|
| 2016 |
Arevalo MT, Wong TM, Ross TM. Expression and Purification of Virus-like Particles for Vaccination. Journal of Visualized Experiments : Jove. PMID 27286040 DOI: 10.3791/54041 |
0.547 |
|
| 2016 |
Wong TM, Petrovsky N, Bissel SJ, Wiley CA, Ross TM. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Human Vaccines & Immunotherapeutics. 1-10. PMID 27215855 DOI: 10.1080/21645515.2016.1162931 |
0.619 |
|
| 2016 |
Tripp RA, Ross T. Development of a Zika vaccine. Expert Review of Vaccines. PMID 27212079 DOI: 10.1080/14760584.2016.1192474 |
0.545 |
|
| 2016 |
Carter DM, Darby CA, LeFoley BC, Crevar CJ, Alefantis T, Oomen R, Anderson SF, Strugnell T, Cortés-Garcia G, Vogel TU, Parrington M, Kleanthous H, Ross TM. Design and Characterization of a COBRA HA vaccine for H1N1 influenza viruses. Journal of Virology. PMID 26912624 DOI: 10.1128/Jvi.03152-15 |
0.641 |
|
| 2016 |
Kaynar AM, Nowalk MP, Lin CJ, Moehling KK, Susick M, Bakalov V, Pitt BR, Bain DJ, Ross TM, Saul SG, Zimmerman RK. Are plasma mineral levels related to antibody response to influenza vaccination in older adults? Human Vaccines & Immunotherapeutics. 0. PMID 26751915 DOI: 10.1080/21645515.2015.1113358 |
0.558 |
|
| 2015 |
Wong TM, Ross TM. Use of computational and recombinant technologies for developing novel influenza vaccines. Expert Review of Vaccines. 1-11. PMID 26595182 DOI: 10.1586/14760584.2016.1113877 |
0.595 |
|
| 2015 |
Kirchenbaum GA, Carter DM, Ross TM. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Boosts Hemagglutinin Stalk-Specific Antibodies. Journal of Virology. PMID 26559834 DOI: 10.1128/Jvi.02372-15 |
0.56 |
|
| 2015 |
Wiley CA, Bhardwaj N, Ross TM, Bissel SJ. Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus. Brain Pathology (Zurich, Switzerland). 25: 634-50. PMID 26276027 DOI: 10.1111/Bpa.12281 |
0.641 |
|
| 2015 |
Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Journal of Virology. 89: 10612-24. PMID 26269188 DOI: 10.1128/Jvi.01526-15 |
0.609 |
|
| 2015 |
Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Reports. 12: 1-6. PMID 26119736 DOI: 10.1016/J.Celrep.2015.06.005 |
0.602 |
|
| 2015 |
Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. Journal of Virology. 89: 8011-25. PMID 26018150 DOI: 10.1128/Jvi.00845-15 |
0.492 |
|
| 2015 |
Price I, Mochan-Keef ED, Swigon D, Ermentrout GB, Lukens S, Toapanta FR, Ross TM, Clermont G. The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study. Journal of Theoretical Biology. 374: 83-93. PMID 25843213 DOI: 10.1016/J.Jtbi.2015.03.017 |
0.765 |
|
| 2015 |
Crevar CJ, Carter DM, Lee KY, Ross TM. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. Human Vaccines & Immunotherapeutics. 11: 572-83. PMID 25671661 DOI: 10.1080/21645515.2015.1012013 |
0.647 |
|
| 2015 |
Nace DA, Lin CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. The Journal of Infectious Diseases. 211: 1915-24. PMID 25525051 DOI: 10.1093/Infdis/Jiu622 |
0.512 |
|
| 2015 |
Carter DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, Isakova-Sivak I, Rudenko L, Ross TM. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine. Vaccine. 33: 108-16. PMID 25448100 DOI: 10.1016/J.Vaccine.2014.11.008 |
0.639 |
|
| 2014 |
Rekstin A, Desheva Y, Kiseleva I, Ross T, Swayne D, Rudenko L. Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models. The Open Microbiology Journal. 8: 154-62. PMID 25685247 DOI: 10.2174/1874285801408010154 |
0.586 |
|
| 2014 |
Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, ... ... Ross TM, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America. 111: 15798-803. PMID 25331901 DOI: 10.1073/Pnas.1409171111 |
0.524 |
|
| 2014 |
Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. Vaccine. 32: 6421-32. PMID 25284811 DOI: 10.1016/J.Vaccine.2014.09.049 |
0.607 |
|
| 2014 |
Kling HM, Nau GJ, Ross TM, Evans TG, Chakraborty K, Empey KM, Flynn JL. Challenges and future in vaccines, drug development, and immunomodulatory therapy. Annals of the American Thoracic Society. 11: S201-10. PMID 25148426 DOI: 10.1513/Annalsats.201401-036Pl |
0.533 |
|
| 2014 |
Ross TM, Pereira LE, Luckay A, McNicholl JM, García-Lerma JG, Heneine W, Eugene HS, Pierce-Paul BR, Zhang J, Hendry RM, Smith JM. A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunity. Aids Research and Human Retroviruses. 30: 1072-81. PMID 24914761 DOI: 10.1089/AID.2014.0030 |
0.831 |
|
| 2014 |
Iheagwara UK, Beatty PL, Van PT, Ross TM, Minden JS, Finn OJ. Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance. Cancer Immunology Research. 2: 263-73. PMID 24778322 DOI: 10.1158/2326-6066.Cir-13-0125 |
0.502 |
|
| 2014 |
Kirchenbaum GA, Ross TM. Eliciting broadly protective antibody responses against influenza. Current Opinion in Immunology. 28: 71-6. PMID 24632083 DOI: 10.1016/J.Coi.2014.02.005 |
0.654 |
|
| 2014 |
Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK, Sambhara S, Sundaram ME, Friedrich T, Sauereisen S, Bloom CE, Zimmerman RK. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. Human Vaccines & Immunotherapeutics. 10: 1195-203. PMID 24614078 DOI: 10.4161/Hv.28313 |
0.575 |
|
| 2014 |
De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA, Ross TM, Martin W. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Human Vaccines & Immunotherapeutics. 10: 256-62. PMID 24525618 DOI: 10.4161/Hv.28135 |
0.614 |
|
| 2014 |
Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzmán CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. Journal of Virology. 88: 4123-31. PMID 24478442 DOI: 10.1128/Jvi.03644-13 |
0.771 |
|
| 2014 |
Soloff AC, Bissel SJ, Junecko BF, Giles BM, Reinhart TA, Ross TM, Barratt-Boyes SM. Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates. The Journal of Infectious Diseases. 209: 2012-6. PMID 24403559 DOI: 10.1093/Infdis/Jiu009 |
0.805 |
|
| 2014 |
Bissel SJ, Wang G, Carter DM, Crevar CJ, Ross TM, Wiley CA. H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis. Journal of Virology. 88: 3077-91. PMID 24371072 DOI: 10.1128/Jvi.01840-13 |
0.52 |
|
| 2014 |
Gopal R, Rangel-Moreno J, Fallert Junecko BA, Mallon DJ, Chen K, Pociask DA, Connell TD, Reinhart TA, Alcorn JF, Ross TM, Kolls JK, Khader SA. Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection. The American Journal of Pathology. 184: 55-63. PMID 24183780 DOI: 10.1016/J.Ajpath.2013.09.012 |
0.546 |
|
| 2014 |
Ross TM. Universal influenza vaccines: Prevention of infection against matched and mismatched strains Journal of Vaccines and Vaccination. DOI: 10.4172/2157-7560.S1.020 |
0.576 |
|
| 2013 |
McHugh KJ, Mandalapu S, Kolls JK, Ross TM, Alcorn JF. A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity. Plos One. 8: e82865. PMID 24324838 DOI: 10.1371/Journal.Pone.0082865 |
0.442 |
|
| 2013 |
Moncla LH, Ross TM, Dinis JM, Weinfurter JT, Mortimer TD, Schultz-Darken N, Brunner K, Capuano SV, Boettcher C, Post J, Johnson M, Bloom CE, Weiler AM, Friedrich TC. A novel nonhuman primate model for influenza transmission. Plos One. 8: e78750. PMID 24244352 DOI: 10.1371/Journal.Pone.0078750 |
0.495 |
|
| 2013 |
Moise L, Tassone R, Latimer H, Terry F, Levitz L, Haran JP, Ross TM, Boyle CM, Martin WD, De Groot AS. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice. Human Vaccines & Immunotherapeutics. 9: 2060-8. PMID 24045788 DOI: 10.4161/Hv.26511 |
0.622 |
|
| 2013 |
Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of Experimental Medicine. 210: 1493-500. PMID 23857983 DOI: 10.1084/Jem.20130212 |
0.473 |
|
| 2013 |
De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin W. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Human Vaccines & Immunotherapeutics. 9: 950-6. PMID 23807079 DOI: 10.4161/Hv.24939 |
0.599 |
|
| 2013 |
Limberis MP, Adam VS, Wong G, Gren J, Kobasa D, Ross TM, Kobinger GP, Tretiakova A, Wilson JM. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Science Translational Medicine. 5: 187ra72. PMID 23720583 DOI: 10.1126/Scitranslmed.3006299 |
0.52 |
|
| 2013 |
Eugene HS, Pierce-Paul BR, Cragio JK, Ross TM. Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge. Virology Journal. 10: 102. PMID 23548077 DOI: 10.1186/1743-422X-10-102 |
0.829 |
|
| 2013 |
León AJ, Banner D, Xu L, Ran L, Peng Z, Yi K, Chen C, Xu F, Huang J, Zhao Z, Lin Z, Huang SH, Fang Y, Kelvin AA, Ross TM, et al. Sequencing, annotation, and characterization of the influenza ferret infectome. Journal of Virology. 87: 1957-66. PMID 23236062 DOI: 10.1128/Jvi.02476-12 |
0.563 |
|
| 2013 |
Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM. Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. Journal of Virology. 87: 1400-10. PMID 23115287 DOI: 10.1128/Jvi.02257-12 |
0.528 |
|
| 2013 |
Larionova N, Kiseleva I, Isakova-Sivak I, Rekstin A, Dubrovina I, Bazhenova E, Ross TM, Swayne D, Gubareva L, Tsvetnitsky V, Fedorova E, Doroshenko E, Rudenko L. Live attenuated influenza vaccines against highly pathogenic H5N1avian influenza: Development and preclinical characterization Journal of Vaccines and Vaccination. 4. DOI: 10.4172/2157-7560.1000208 |
0.604 |
|
| 2012 |
Verma S, Dimitrova M, Munjal A, Fontana J, Crevar CJ, Carter DM, Ross TM, Khurana S, Golding H. Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies. Journal of Virology. 86: 12283-93. PMID 22951833 DOI: 10.1128/Jvi.01596-12 |
0.629 |
|
| 2012 |
Carter DM, Lu HR, Bloom CE, Crevar CJ, Cherry JL, Lipman DJ, Ross TM. Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains. Plos One. 7: e39435. PMID 22815705 DOI: 10.1371/Journal.Pone.0039435 |
0.495 |
|
| 2012 |
Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz-Cherry S, Wiley CA, Ross TM. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. The Journal of Infectious Diseases. 205: 1562-70. PMID 22448011 DOI: 10.1093/Infdis/Jis232 |
0.869 |
|
| 2012 |
Soloff AC, Weirback HK, Ross TM, Barratt-Boyes SM. Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection. Comparative Immunology, Microbiology and Infectious Diseases. 35: 309-17. PMID 22421538 DOI: 10.1016/J.Cimid.2012.01.012 |
0.451 |
|
| 2012 |
Giles BM, Ross TM. Computationally optimized antigens to overcome influenza viral diversity. Expert Review of Vaccines. 11: 267-9. PMID 22380818 DOI: 10.1586/Erv.12.3 |
0.809 |
|
| 2012 |
Verma N, Dimitrova M, Carter DM, Crevar CJ, Ross TM, Golding H, Khurana S. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children. Journal of Virology. 86: 5515-22. PMID 22379097 DOI: 10.1128/Jvi.07085-11 |
0.444 |
|
| 2012 |
McBurney SP, Landucci G, Forthal DN, Ross TM. Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine. Aids Research and Human Retroviruses. 28: 1063-72. PMID 22214267 DOI: 10.1089/Aid.2011.0351 |
0.858 |
|
| 2012 |
Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. Clinical and Vaccine Immunology : Cvi. 19: 128-39. PMID 22190399 DOI: 10.1128/Cvi.05533-11 |
0.872 |
|
| 2012 |
Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. Journal of Virology. 86: 1500-13. PMID 22130546 DOI: 10.1128/Jvi.06034-11 |
0.87 |
|
| 2012 |
Wiley CA, Carter DM, Ross TM, Bissel SJ. Absence of fetal transmission of H1N1 despite severe maternal infection. Influenza and Other Respiratory Viruses. 6: e1. PMID 22103260 DOI: 10.1111/J.1750-2659.2011.00310.X |
0.415 |
|
| 2012 |
Ross TM, Bhardwaj N, Bissel SJ, Hartman AL, Smith DR. Animal models of Rift Valley fever virus infection. Virus Research. 163: 417-23. PMID 22086058 DOI: 10.1016/J.Virusres.2011.10.023 |
0.606 |
|
| 2012 |
Schneider-Ohrum K, Ross TM. Virus-like particles for antigen delivery at mucosal surfaces. Current Topics in Microbiology and Immunology. 354: 53-73. PMID 21744306 DOI: 10.1007/82_2011_135 |
0.569 |
|
| 2012 |
Bissel SJ, Giles BM, Wang G, Olevian DC, Ross TM, Wiley CA. Acute murine H5N1 influenza A encephalitis. Brain Pathology (Zurich, Switzerland). 22: 150-8. PMID 21714828 DOI: 10.1111/J.1750-3639.2011.00514.X |
0.814 |
|
| 2012 |
Scott J, Gulzar N, Klaric K, Ross T, Lu S, Wang S. DNA vaccines that express the MPER of HIV-1 gp41 elicit different antibodies depending upon their transmembrane and cytoplasmic domains Retrovirology. 9: 348. DOI: 10.1186/1742-4690-9-S2-P348 |
0.5 |
|
| 2011 |
Pegu P, Helmus R, Gupta P, Tarwater P, Caruso L, Shen C, Ross T, Chen Y. Induction of strong anti-HIV cellular immunity by a combination of Clostridium perfringens expressing HIV gag and virus like particles. Current Hiv Research. 9: 613-22. PMID 22211658 DOI: 10.2174/157016211798998808 |
0.498 |
|
| 2011 |
Ross TM, Hairong L, Chia BS, Hill E, Weirback H, Zimmer S. Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA. Plos Currents. 3: RRN1265. PMID 22037352 DOI: 10.1371/Currents.Rrn1265 |
0.532 |
|
| 2011 |
Schneider-Ohrum K, Giles BM, Weirback HK, Williams BL, DeAlmeida DR, Ross TM. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine. 29: 9081-92. PMID 21963872 DOI: 10.1016/J.Vaccine.2011.09.051 |
0.863 |
|
| 2011 |
Tang XC, Lu HR, Ross TM. Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge. Viral Immunology. 24: 311-9. PMID 21830902 DOI: 10.1089/Vim.2011.0016 |
0.654 |
|
| 2011 |
Zinman G, Brower-Sinning R, Emeche CH, Ernst J, Huang GT, Mahony S, Myers AJ, O'Dee DM, Flynn JL, Nau GJ, Ross TM, Salter RD, Benos PV, Bar Joseph Z, Morel PA. Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque. Plos One. 6: e22401. PMID 21789257 DOI: 10.1371/Journal.Pone.0022401 |
0.375 |
|
| 2011 |
Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Mathematical Biosciences. 231: 186-96. PMID 21385589 DOI: 10.1016/J.Mbs.2011.03.005 |
0.662 |
|
| 2011 |
Giles BM, Ross TM. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine. 29: 3043-54. PMID 21320540 DOI: 10.1016/J.Vaccine.2011.01.100 |
0.865 |
|
| 2011 |
Petrovsky N, Ross TM. Challenges in improving influenza vaccine protection in the elderly. Expert Review of Vaccines. 10: 7-11. PMID 21162614 DOI: 10.1586/Erv.10.153 |
0.603 |
|
| 2011 |
Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, Wenzel S, Erzurum SC, Fitzpatrick AM, Teague WG, Jarjour N, Moore WC, Sumino K, Simeone S, Ratanamaneechat S, ... ... Ross TM, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. The Journal of Allergy and Clinical Immunology. 127: 130-7, 137.e1-3. PMID 21145578 DOI: 10.1016/J.Jaci.2010.11.014 |
0.542 |
|
| 2011 |
Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. Journal of Virology. 85: 1246-56. PMID 21084473 DOI: 10.1128/Jvi.02107-10 |
0.605 |
|
| 2011 |
Ross TM, Bhardwaj N, Eugene HS, Giles BM, McBurney SP, Rossi SL, Schneider-Ohrum K, Tang XC. Virus-Like Particle Vaccines: Advantages and Challenges Development of Vaccines: From Discovery to Clinical Testing. 97-124. DOI: 10.1002/9781118023648.ch4 |
0.795 |
|
| 2010 |
Tang XC, Lu HR, Ross TM. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine. 28: 6821-31. PMID 20727393 DOI: 10.1016/J.Vaccine.2010.08.040 |
0.588 |
|
| 2010 |
Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, Zimmerman RK, Ostroff SM, Lee BY, Burke DS, Ross TM. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. Plos One. 5: e11601. PMID 20644650 DOI: 10.1371/Journal.Pone.0011601 |
0.796 |
|
| 2010 |
Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. Plos One. 5: e11548. PMID 20634959 DOI: 10.1371/Journal.Pone.0011548 |
0.61 |
|
| 2010 |
Bhardwaj N, Heise MT, Ross TM. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. Plos Neglected Tropical Diseases. 4: e725. PMID 20582312 DOI: 10.1371/Journal.Pntd.0000725 |
0.721 |
|
| 2010 |
Movsesyan N, Davtyan H, Mkrtichyan M, Petrushina I, Tiraturyan T, Ross T, Agadjanyan MG, Ghochikyan A, Cribbs DH. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology. Human Gene Therapy. 21: 1569-76. PMID 20528468 DOI: 10.1089/Hum.2009.219 |
0.512 |
|
| 2010 |
Ross TM. Dengue virus. Clinics in Laboratory Medicine. 30: 149-60. PMID 20513545 DOI: 10.1016/j.cll.2009.10.007 |
0.396 |
|
| 2010 |
Rossi SL, Ross TM, Evans JD. West Nile virus. Clinics in Laboratory Medicine. 30: 47-65. PMID 20513541 DOI: 10.1016/j.cll.2009.10.006 |
0.348 |
|
| 2010 |
Dunn MD, Rossi SL, Carter DM, Vogt MR, Mehlhop E, Diamond MS, Ross TM. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Virology Journal. 7: 95. PMID 20462412 DOI: 10.1186/1743-422X-7-95 |
0.559 |
|
| 2010 |
Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, ... Ross TM, et al. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology. 401: 257-65. PMID 20334888 DOI: 10.1016/J.Virol.2010.02.020 |
0.491 |
|
| 2010 |
Ross T, Zimmer S, Burke D, Crevar C, Carter D, Stark J, Giles B, Zimmerman R, Ostroff S, Lee B. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. Plos Currents. 2: RRN1148. PMID 20191082 DOI: 10.1371/Currents.Rrn1148 |
0.799 |
|
| 2010 |
Toapanta FR, DeAlmeida DR, Dunn MD, Ross TM. C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunology Letters. 129: 32-8. PMID 20064559 DOI: 10.1016/J.Imlet.2009.12.022 |
0.685 |
|
| 2009 |
Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory Research. 10: 112. PMID 19922665 DOI: 10.1186/1465-9921-10-112 |
0.772 |
|
| 2009 |
Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 5301-10. PMID 19783685 DOI: 10.4049/Jimmunol.0900995 |
0.324 |
|
| 2009 |
Ross TM, Mahmood K, Crevar CJ, Schneider-Ohrum K, Heaton PM, Bright RA. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. Plos One. 4: e6032. PMID 19554101 DOI: 10.1371/Journal.Pone.0006032 |
0.682 |
|
| 2009 |
McBurney SP, Ross TM. Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine. 27: 4337-49. PMID 19389453 DOI: 10.1016/J.Vaccine.2009.04.032 |
0.856 |
|
| 2009 |
Brower-Sinning R, Carter DM, Crevar CJ, Ghedin E, Ross TM, Benos PV. The role of RNA folding free energy in the evolution of the polymerase genes of the influenza A virus. Genome Biology. 10: R18. PMID 19216739 DOI: 10.1186/Gb-2009-10-2-R18 |
0.401 |
|
| 2009 |
Sodora DL, Ross TM. Simian immunodeficiency virus pathogenesis. Current Hiv Research. 7: 1. PMID 19149548 DOI: 10.2174/157016209787048555 |
0.439 |
|
| 2009 |
Price I, Swigon D, Ermentrout B, Toapanta F, Ross T, Clermont G. Immune response to influenza A Journal of Critical Care. 24: e33. DOI: 10.1016/J.Jcrc.2009.06.039 |
0.502 |
|
| 2008 |
McBurney SP, Ross TM. Viral sequence diversity: challenges for AIDS vaccine designs. Expert Review of Vaccines. 7: 1405-17. PMID 18980542 DOI: 10.1586/14760584.7.9.1405 |
0.849 |
|
| 2008 |
Crevar CJ, Ross TM. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virology Journal. 5: 131. PMID 18957098 DOI: 10.1186/1743-422X-5-131 |
0.655 |
|
| 2008 |
Movsesyan N, Mkrtichyan M, Petrushina I, Ross TM, Cribbs DH, Agadjanyan MG, Ghochikyan A. DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype. Journal of Neuroimmunology. 205: 57-63. PMID 18838175 DOI: 10.1016/J.Jneuroim.2008.08.016 |
0.479 |
|
| 2008 |
Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine. 26: 5393-9. PMID 18706956 DOI: 10.1016/J.Vaccine.2008.07.084 |
0.642 |
|
| 2008 |
Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 26: 3352-61. PMID 18468740 DOI: 10.1016/J.Vaccine.2008.03.055 |
0.661 |
|
| 2008 |
Balin SJ, Ross TM, Platt JL, Cascalho M. HIV genes diversify in B cells. Current Hiv Research. 6: 10-8. PMID 18288970 DOI: 10.2174/157016208783571919 |
0.352 |
|
| 2008 |
Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. Plos One. 3: e1501. PMID 18231588 DOI: 10.1371/Journal.Pone.0001501 |
0.846 |
|
| 2008 |
Mkrtichyan M, Ghochikyan A, Movsesyan N, Karapetyan A, Begoyan G, Yu J, Glenn GM, Ross TM, Agadjanyan MG, Cribbs DH. Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization. Dna and Cell Biology. 27: 19-24. PMID 17961074 DOI: 10.1089/Dna.2007.0639 |
0.539 |
|
| 2007 |
Karkhanis LU, Ross TM. Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses. Current Pharmaceutical Design. 13: 2015-23. PMID 17627535 DOI: 10.2174/138161207781039832 |
0.561 |
|
| 2007 |
McBurney SP, Ross TM. Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines. Current Pharmaceutical Design. 13: 1957-64. PMID 17627529 DOI: 10.2174/138161207781039841 |
0.836 |
|
| 2007 |
Toapanta FR, Craigo JK, Montelaro RC, Ross TM. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Current Hiv Research. 5: 199-209. PMID 17346134 DOI: 10.2174/157016207780077057 |
0.768 |
|
| 2007 |
Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 25: 3871-8. PMID 17337102 DOI: 10.1016/J.Vaccine.2007.01.106 |
0.853 |
|
| 2007 |
McBurney SP, Young KR, Ross TM. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology. 358: 334-46. PMID 17011011 DOI: 10.1016/J.Virol.2006.08.032 |
0.829 |
|
| 2007 |
Ross TM. Editorial: Vaccines and immunity Current Pharmaceutical Design. 13: 1955. DOI: 10.2174/138161207781039823 |
0.558 |
|
| 2007 |
Ohta R, Imai M, He C, Ross TM, Tomlinson S. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with MUC1-C3d fusion protein Molecular Immunology. 44: 221. DOI: 10.1016/J.Molimm.2006.07.173 |
0.363 |
|
| 2006 |
Toapanta FR, Ross TM. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunologic Research. 36: 197-210. PMID 17337780 DOI: 10.1385/Ir:36:1:197 |
0.703 |
|
| 2006 |
McBurney SP, Young KR, Nwaigwe CI, Soloff AC, Cole KS, Ross TM. Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. Current Hiv Research. 4: 475-84. PMID 17073623 DOI: 10.2174/157016206778560018 |
0.835 |
|
| 2006 |
Young KR, McBurney SP, Karkhanis LU, Ross TM. Virus-like particles: designing an effective AIDS vaccine. Methods (San Diego, Calif.). 40: 98-117. PMID 16997718 DOI: 10.1016/J.Ymeth.2006.05.024 |
0.857 |
|
| 2006 |
Bower JF, Ross TM. A minimum CR2 binding domain of C3d enhances immunity following vaccination. Advances in Experimental Medicine and Biology. 586: 249-64. PMID 16893077 DOI: 10.1007/0-387-34134-X_17 |
0.413 |
|
| 2006 |
Bower JF, Li Y, Wyatt R, Ross TM. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine. 24: 5442-51. PMID 16621193 DOI: 10.1016/J.Vaccine.2006.03.063 |
0.486 |
|
| 2006 |
Young KR, Ross TM. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. Aids Research and Human Retroviruses. 22: 99-108. PMID 16438652 DOI: 10.1089/Aid.2006.22.99 |
0.58 |
|
| 2005 |
Bower JF, Sanders KL, Ross TM. C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. Current Hiv Research. 3: 191-8. PMID 15853723 DOI: 10.2174/1570162053506937 |
0.52 |
|
| 2005 |
Bower J, Toapanta F, Young K, Ross T. Retrovirology. 2: S119. DOI: 10.1186/1742-4690-2-S1-S119 |
0.775 |
|
| 2005 |
Toapanta F, Ross T. Retrovirology. 2: P96. DOI: 10.1186/1742-4690-2-S1-P96 |
0.791 |
|
| 2004 |
Young KR, Teal BE, Brooks Y, Green TD, Bower JF, Ross TM. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies. Aids Research and Human Retroviruses. 20: 1259-68. PMID 15588348 DOI: 10.1089/Aid.2004.20.1259 |
0.487 |
|
| 2004 |
Ho PT, Teal BE, Ross TM. Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity. Virology. 329: 109-18. PMID 15476879 DOI: 10.1016/J.Virol.2004.07.028 |
0.314 |
|
| 2004 |
Bower JF, Green TD, Ross TM. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Virology. 328: 292-300. PMID 15464849 DOI: 10.1016/J.Virol.2004.07.031 |
0.526 |
|
| 2004 |
Young KR, Smith JM, Ross TM. Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology. 327: 262-72. PMID 15351214 DOI: 10.1016/J.Virol.2004.07.009 |
0.579 |
|
| 2004 |
Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Journal of Immunology (Baltimore, Md. : 1950). 172: 5833-7. PMID 15128761 DOI: 10.4049/Jimmunol.172.10.5833 |
0.693 |
|
| 2004 |
Bower JF, Yang X, Sodroski J, Ross TM. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. Journal of Virology. 78: 4710-9. PMID 15078953 DOI: 10.1128/Jvi.78.9.4710-4719.2004 |
0.527 |
|
| 2004 |
Toapanta FR, Ross TM. Mouse strain-dependent differences in enhancement of immune responses by C3d. Vaccine. 22: 1773-81. PMID 15068861 DOI: 10.1016/J.Vaccine.2003.10.050 |
0.793 |
|
| 2004 |
Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine. 22: 1764-72. PMID 15068860 DOI: 10.1016/J.Vaccine.2003.09.054 |
0.468 |
|
| 2003 |
Watanabe I, Ross TM, Tamura S, Ichinohe T, Ito S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine. 21: 4532-8. PMID 14575764 DOI: 10.1016/S0264-410X(03)00510-3 |
0.585 |
|
| 2003 |
Young KR, Ross TM. Particle-based vaccines for HIV-1 infection. Current Drug Targets. Infectious Disorders. 3: 151-69. PMID 12769792 DOI: 10.2174/1568005033481213 |
0.609 |
|
| 2003 |
Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM. Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology. 308: 270-8. PMID 12706077 DOI: 10.1016/S0042-6822(03)00008-4 |
0.54 |
|
| 2003 |
Mitchell JA, Green TD, Bright RA, Ross TM. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine. 21: 902-14. PMID 12547601 DOI: 10.1016/S0264-410X(02)00539-X |
0.559 |
|
| 2003 |
Green TD, Montefiori DC, Ross TM. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. Journal of Virology. 77: 2046-55. PMID 12525639 DOI: 10.1128/JVI.77.3.2046-2055.2003 |
0.404 |
|
| 2001 |
Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM. C3d enhancement of neutralizing antibodies to measles hemagglutinin Vaccine. 20: 242-248. PMID 11567770 DOI: 10.1016/S0264-410X(01)00266-3 |
0.433 |
|
| 2001 |
Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins Aids Research and Human Retroviruses. 17: 829-835. PMID 11429124 DOI: 10.1089/088922201750252025 |
0.459 |
|
| 2000 |
Ross TM, Xu Y, Bright RA, Robinson HL. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge Nature Immunology. 1: 127-131. PMID 11248804 DOI: 10.1038/77802 |
0.462 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Sahajpal NS, Mondal AK, Njau A, Petty Z, Chen J, Ananth S, Ahluwalia P, Williams C, Ross TM, Chaubey A, DeSantis G, Schroth GP, Bahl J, Kolhe R. High-Throughput Next-Generation Sequencing Respiratory Viral Panel: A Diagnostic and Epidemiologic Tool for SARS-CoV-2 and Other Viruses. Viruses. 13. PMID 34696495 DOI: 10.3390/v13102063 |
0.292 |
|
| 2022 |
Gupta T, Somanna N, Rowe T, LaGatta M, Helms S, Owino SO, Jelesijevic T, Harvey S, Jacobs W, Voss T, Sakamoto K, Day C, Whalen C, Karls R, He B, ... ... Ross T, et al. Ferrets as a model for tuberculosis transmission. Frontiers in Cellular and Infection Microbiology. 12: 873416. PMID 36051240 DOI: 10.3389/fcimb.2022.873416 |
0.279 |
|
| 2020 |
Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, ... ... Ross TM, et al. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection. Biorxiv : the Preprint Server For Biology. PMID 33398272 DOI: 10.1101/2020.12.28.424554 |
0.276 |
|
| 2022 |
Forst CV, Martin-Sancho L, Tripathi S, Wang G, Dos Anjos Borges LG, Wang M, Geber A, Lashua L, Ding T, Zhou X, Carter CE, Metreveli G, Rodriguez-Frandsen A, Urbanowski MD, White KM, ... ... Ross TM, et al. Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans. Science Advances. 8: eabm5859. PMID 36197970 DOI: 10.1126/sciadv.abm5859 |
0.272 |
|
| 2021 |
Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, ... ... Ross TM, et al. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. PMID 33691139 DOI: 10.1016/j.cell.2021.02.026 |
0.27 |
|
| 2022 |
Wang C, Lashua LP, Carter CE, Johnson SK, Wang M, Ross TM, Ghedin E, Zhang B, Forst CV. Sex disparities in influenza: A multiscale network analysis. Iscience. 25: 104192. PMID 35479404 DOI: 10.1016/j.isci.2022.104192 |
0.266 |
|
| 2021 |
Köppert S, Wolf C, Becza N, Sautto GA, Franke F, Kuerten S, Ross TM, Lehmann PV, Kirchenbaum GA. Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays. Cells. 10. PMID 34440612 DOI: 10.3390/cells10081843 |
0.265 |
|
| 2023 |
Pilewski KA, Wall S, Richardson SI, Manamela NP, Clark K, Hermanus T, Binshtein E, Venkat R, Sautto GA, Kramer KJ, Shiakolas AR, Setliff I, Salas J, Mapengo RE, Suryadevara N, ... ... Ross TM, et al. Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor. Cell Reports. 42: 112044. PMID 36708513 DOI: 10.1016/j.celrep.2023.112044 |
0.262 |
|
| 2020 |
Jang H, Ross TM. Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h. Veterinary Microbiology. 251: 108907. PMID 33129043 DOI: 10.1016/j.vetmic.2020.108907 |
0.255 |
|
| 2008 |
Morris A, Netravali M, Kling HM, Shipley T, Ross T, Sciurba FC, Norris KA. Relationship of Pneumocystis Antibody Response to Severity of Chronic Obstructive Pulmonary Disease Clinical Infectious Diseases. 47. PMID 18724825 DOI: 10.1086/591701 |
0.254 |
|
| 2015 |
De Groot AS, Ross TM, Levitz L, Messitt TJ, Tassone R, Boyle CM, Vincelli AJ, Moise L, Martin W, Knopf PM. C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells. Immunology and Cell Biology. 93: 189-97. PMID 25385064 DOI: 10.1038/Icb.2014.89 |
0.252 |
|
| 1998 |
Bogerd HP, Echarri A, Ross TM, Cullen BR. Inhibition of Human Immunodeficiency Virus Rev and Human T-Cell Leukemia Virus Rex Function, but Not Mason-Pfizer Monkey Virus Constitutive Transport Element Activity, by a Mutant Human Nucleoporin Targeted to Crm1 Journal of Virology. 72: 8627-8635. DOI: 10.1128/jvi.72.11.8627-8635.1998 |
0.247 |
|
| 2004 |
Ross T. Editorial [Hot Topic: Anti-HIV Drug Design and Therapy (Executive Editor: Ted M. Ross)] Current Pharmaceutical Design. 10: 4003-4003. DOI: 10.2174/1381612043382486 |
0.247 |
|
| 2019 |
Doolan DL, Ross TM. 2018 ISV Congress: advances in the 100 years since the world's deadliest pandemic. Human Vaccines & Immunotherapeutics. 15: 2006-2008. PMID 31557126 DOI: 10.1080/21645515.2019.1660544 |
0.246 |
|
| 2003 |
Ross T. Preface [Hot Topic: Anti-HIV Drugs and Therapy (Executive Editor : Ted M. Ross)]. Current Pharmaceutical Design.. 9: 1-2. DOI: 10.2174/1381612033454694 |
0.246 |
|
| 1999 |
Ross TM, Bieniasz PD, Cullen BR. Role of chemokine receptors in HIV-1 infection and pathogenesis Advances in Virus Research. 52: 233-267. PMID 10384237 DOI: 10.1016/S0065-3527(08)60300-0 |
0.235 |
|
| 2022 |
Sahajpal NS, Mondal AK, Ananth S, Njau A, Jones K, Ahluwalia P, Oza E, Ross TM, Kota V, Kothandaraman A, Fulzele S, Hegde M, Chaubey A, Rojiani AM, Kolhe R. Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and B. Scientific Reports. 12: 3480. PMID 35241679 DOI: 10.1038/s41598-022-07152-0 |
0.223 |
|
| 2024 |
Johnson NV, Wall SC, Kramer KJ, Holt CM, Periasamy S, Richardson S, Suryadevara N, Andreano E, Paciello I, Pierleoni G, Piccini G, Huang Y, Ge P, Allen JD, Uno N, ... ... Ross TM, et al. Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody. Biorxiv : the Preprint Server For Biology. PMID 38293237 DOI: 10.1101/2024.01.15.575741 |
0.218 |
|
| 2021 |
Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, Manenti A, Pantano E, Kabanova A, Troisi M, Vacca F, Cardamone D, De Santi C, Torres JL, Ozorowski G, ... ... Ross TM, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. PMID 33667349 DOI: 10.1016/j.cell.2021.02.035 |
0.217 |
|
| 1998 |
Ross TM, Bieniasz PD, Cullen BR. Multiple Residues Contribute to the Inability of Murine CCR-5 To Function as a Coreceptor for Macrophage-Tropic Human Immunodeficiency Virus Type 1 Isolates Journal of Virology. 72: 1918-1924. DOI: 10.1128/jvi.72.3.1918-1924.1998 |
0.216 |
|
| 1995 |
Green PL, Ross TM, Chen IS, Pettiford S. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. Journal of Virology. 69: 387-394. DOI: 10.1128/jvi.69.1.387-394.1995 |
0.208 |
|
| 1999 |
Ross TM, Oran AE, Cullen BR. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein Current Biology. 9: 613-621. PMID 10375525 DOI: 10.1016/S0960-9822(99)80283-8 |
0.206 |
|
| 2022 |
Gadush MV, Sautto GA, Chandrasekaran H, Bensussan A, Ross TM, Ippolito GC, Person MD. Template-Assisted Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry. Journal of Proteome Research. PMID 35653804 DOI: 10.1021/acs.jproteome.1c00913 |
0.2 |
|
| 2021 |
Allgoewer K, Maity S, Zhao A, Lashua L, Ramgopal M, Balkaran BN, Liu L, Purushwani S, Arévalo MT, Ross TM, Choi H, Ghedin E, Vogel C. New proteomic signatures to distinguish between Zika and dengue infections. Molecular & Cellular Proteomics : McP. 100052. PMID 33582300 DOI: 10.1016/j.mcpro.2021.100052 |
0.192 |
|
| 2010 |
Craigo JK, Ross TM. Animal lentiviruses. Editorial. Current Hiv Research. 8: 1. PMID 20238449 DOI: 10.2174/157016210790416433 |
0.191 |
|
| 2014 |
Stevenson HP, Makhov AM, Calero M, Edwards AL, Zeldin OB, Mathews II, Lin G, Barnes CO, Santamaria H, Ross TM, Soltis SM, Khosla C, Nagarajan V, Conway JF, Cohen AE, et al. Use of transmission electron microscopy to identify nanocrystals of challenging protein targets. Proceedings of the National Academy of Sciences of the United States of America. 111: 8470-5. PMID 24872454 DOI: 10.1073/Pnas.1400240111 |
0.187 |
|
| 1998 |
Ross TM, Cullen BR. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop Proceedings of the National Academy of Sciences of the United States of America. 95: 7682-7686. PMID 9636210 DOI: 10.1073/Pnas.95.13.7682 |
0.17 |
|
| 2003 |
Ghochikyan A, Vasilevko V, Petrushina I, Movsesyan N, Babikyan D, Tian W, Sadzikava N, Ross TM, Head E, Cribbs DH, Agadjanyan MG. Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene. European Journal of Immunology. 33: 3232-41. PMID 14635031 DOI: 10.1002/eji.200324000 |
0.168 |
|
| 2015 |
Ross TM. Portrait: Dr. Ted Ross. Human Vaccines & Immunotherapeutics. 0. PMID 26552916 DOI: 10.1080/21645515.2015.1116286 |
0.165 |
|
| 2020 |
Linsky TW, Vergara R, Codina N, Nelson JW, Walker MJ, Su W, Barnes CO, Hsiang TY, Esser-Nobis K, Yu K, Reneer ZB, Hou YJ, Priya T, Mitsumoto M, Pong A, ... ... Ross TM, et al. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2. Science (New York, N.Y.). PMID 33154107 DOI: 10.1126/science.abe0075 |
0.165 |
|
| 1998 |
Mulloy JC, Migone TS, Ross TM, Ton N, Green PL, Leonard WJ, Franchini G. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV- 2(pan-p)) transform T cells independently of Jak/STAT activation Journal of Virology. 72: 4408-4412. PMID 9557732 DOI: 10.1128/Jvi.72.5.4408-4412.1998 |
0.153 |
|
| 2007 |
Cole KS, Ross TM. Antibody neutralization. Current Hiv Research. 5: 505-6. PMID 18045107 DOI: 10.2174/157016207782418551 |
0.142 |
|
| 1996 |
Ross TM, Pettiford SM, Green PL. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. Journal of Virology. 70: 5194-5202. DOI: 10.1128/jvi.70.8.5194-5202.1996 |
0.137 |
|
| 2000 |
Ross TM, Narayan M, Fang ZY, Minella AC, Green PL. Human T-cell leukemia virus type 2 Tax mutants that selectively abrogate NFκB or CREB/ATF activation fail to transform primary human T cells Journal of Virology. 74: 2655-2662. PMID 10684280 DOI: 10.1128/JVI.74.6.2655-2662.2000 |
0.128 |
|
| 2024 |
Shi H, Ross TM. Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine. Expert Review of Vaccines. PMID 38509022 DOI: 10.1080/14760584.2024.2333338 |
0.12 |
|
| 2010 |
Craigo JK, Ross TM. Current HIV Research: Editorial Current Hiv Research. 8: 1. DOI: 10.2174/157016210790416433 |
0.112 |
|
| 2022 |
Ebell MH, Forgacs D, Shen Y, Ross TM, Hulme C, Bentivegna M, Hanley HB, Jefferson AM, Hainess L. High Prevalence of Both Previous Infection with SARS-CoV-2 and Persistent Symptoms. Journal of the American Board of Family Medicine : Jabfm. 35: 570-578. PMID 35641057 DOI: 10.3122/jabfm.2022.03.210348 |
0.107 |
|
| 2015 |
De Groot AS, Ross TM, Levitz L, Messitt TJ, Tassone R, Boyle CM, Vincelli AJ, Moise L, Martin W, Knopf PM. C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells Immunology and Cell Biology. 93: 189-197. DOI: 10.1038/icb.2014.89 |
0.104 |
|
| 2024 |
Pushalkar S, Wu S, Maity S, Pressler M, Rendleman J, Vitrinel B, Jeffery L, Abdelhadi R, Chen M, Ross T, Carlock M, Choi H, Vogel C. Complex changes in serum protein levels in COVID-19 convalescents. Scientific Reports. 14: 4479. PMID 38396092 DOI: 10.1038/s41598-024-54534-7 |
0.103 |
|
| 1997 |
Ross TM, Minella AC, Fang ZY, Pettiford SM, Green PL. Mutational analysis of human T-cell leukemia virus type 2 Tax. Journal of Virology. 71: 8912-7. PMID 9343258 DOI: 10.1128/Jvi.71.11.8912-8917.1997 |
0.09 |
|
| 2008 |
Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH. Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience. 152: 785-97. PMID 18304744 DOI: 10.1016/j.neuroscience.2008.01.013 |
0.075 |
|
| 2022 |
Qin R, Kurz E, Chen S, Zeck B, Chiribogas L, Jackson D, Herchen A, Attia T, Carlock M, Rapkiewicz A, Bar-Sagi D, Ritchie B, Ross TM, Mahal LK. α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade. Medrxiv : the Preprint Server For Health Sciences. PMID 35702159 DOI: 10.1101/2022.06.06.22275981 |
0.074 |
|
| 2022 |
Qin R, Kurz E, Chen S, Zeck B, Chiribogas L, Jackson D, Herchen A, Attia T, Carlock M, Rapkiewicz A, Bar-Sagi D, Ritchie B, Ross TM, Mahal LK. α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade. Acs Infectious Diseases. PMID 36219583 DOI: 10.1021/acsinfecdis.2c00421 |
0.074 |
|
| 1997 |
DeMarini DM, Shelton ML, Warren SH, Ross TM, Shim JY, Richard AM, Pegram RA. Glutathione S-transferase-mediated induction of GC-->AT transitions by halomethanes in Salmonella. Environmental and Molecular Mutagenesis. 30: 440-7. PMID 9435885 DOI: 10.1002/(Sici)1098-2280(1997)30:4<440::Aid-Em9>3.0.Co;2-M |
0.064 |
|
| 2021 |
Sahajpal NS, Mondal AK, Ananth S, Njau A, Ahluwalia P, Newnam G, Lozoya-Colinas A, Hud NV, Kota V, Ross TM, Reid MD, Fulzele S, Chaubey A, Hegde M, Rojiani AM, et al. SalivaSTAT: Direct-PCR and Pooling of Saliva Samples Collected in Healthcare and Community Setting for SARS-CoV-2 Mass Surveillance. Diagnostics (Basel, Switzerland). 11. PMID 34069462 DOI: 10.3390/diagnostics11050904 |
0.052 |
|
| 2002 |
Allis JW, Anderson BP, Zhao G, Ross TM, Pegram RA. Evidence for the involvement of CYP1A2 in the metabolism of bromodichloromethane in rat liver. Toxicology. 176: 25-37. PMID 12062927 DOI: 10.1016/S0300-483X(02)00088-4 |
0.049 |
|
| 2004 |
Ross TM, Martinez PM, Renner JC, Thorne RG, Hanson LR, Frey WH. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. Journal of Neuroimmunology. 151: 66-77. PMID 15145605 DOI: 10.1016/j.jneuroim.2004.02.011 |
0.047 |
|
| 1995 |
Salvino JM, Seoane PR, Douty BD, Awad MA, Hoyer D, Ross TM, Dolle RE, Houck WT, Faunce DM, Sawutz DG. Structure activity relationships of non-peptide bradykinin B2 receptor antagonists Bioorganic and Medicinal Chemistry Letters. 5: 357-362. DOI: 10.1016/0960-894X(95)00035-R |
0.041 |
|
| 2021 |
Sahajpal NS, Mondal AK, Ananth S, Njau A, Ahluwalia P, Kota V, Caspary K, Ross TM, Farrell M, Shannon MP, Fulzele S, Chaubey A, Hegde M, Rojiani AM, Kolhe R. SalivaAll: Clinical validation of a sensitive test for saliva collected in healthcare and community settings with pooling utility for SARS-CoV-2 mass surveillance. The Journal of Molecular Diagnostics : Jmd. PMID 33957320 DOI: 10.1016/j.jmoldx.2021.04.005 |
0.036 |
|
| 2000 |
Scott MK, Ross TM, Lee DH, Wang HY, Shank RP, Wild KD, Davis CB, Crooke JJ, Potocki AC, Reitz AB. 2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor. Bioorganic & Medicinal Chemistry. 8: 1383-91. PMID 10896115 DOI: 10.1016/S0968-0896(00)00062-6 |
0.036 |
|
| 1991 |
Davies DL, Ross TM. Long-term ethanol-exposure markedly changes the cellular composition of cerebral glial cultures Developmental Brain Research. 62: 151-158. PMID 1769095 DOI: 10.1016/0165-3806(91)90162-C |
0.033 |
|
| 1995 |
Prasad CVC, Prouty CP, Hoyer D, Ross TM, Salvino JM, Awad M, Graybill TL, Schmidt SJ, Kelly Osifo I, Dolle RE, Helaszek CT, Miller RE, Ator MA. Structural and stereochemical requirements of time-dependent inactivators of the interleukin-1β converting enzyme Bioorganic and Medicinal Chemistry Letters. 5: 315-318. DOI: 10.1016/0960-894X(95)00027-Q |
0.03 |
|
| 1997 |
Dolle RE, Hoyer D, Rinker JM, Ross TM, Schmidt SJ, Helaszek CT, Ator MA. 3-Chloro-4-carboxamido-6-arylpyridazines as a non-peptide class of interleukin-1β converting enzyme inhibitor Bioorganic and Medicinal Chemistry Letters. 7: 1003-1006. DOI: 10.1016/S0960-894X(97)00145-5 |
0.029 |
|
| 1998 |
Fish EB, Chapman JA, Miller NA, Link MA, Fishell E, Wright B, McCready DR, Hiraki GY, Ross TM, Hanna WM, Lickley HL. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Annals of Surgical Oncology. 5: 724-32. PMID 9869520 |
0.028 |
|
| 2015 |
Ross TM, Battista K, Bignan GC, Brenneman DE, Connolly PJ, Liu J, Middleton SA, Orsini M, Reitz AB, Rosenthal DI, Scott MK, Vaidya AH. A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxiety. Bioorganic & Medicinal Chemistry Letters. 25: 602-6. PMID 25556095 DOI: 10.1016/J.Bmcl.2014.12.015 |
0.026 |
|
| 2012 |
Chesman AS, Yang M, Mallick B, Ross TM, Gass IA, Deacon GB, Batten SR, Mudring AV. Melting point suppression in new lanthanoid(III) ionic liquids by trapping of kinetic polymorphs: an in situ synchrotron powder diffraction study. Chemical Communications (Cambridge, England). 48: 124-6. PMID 22053321 DOI: 10.1039/C1Cc14744G |
0.024 |
|
| 1989 |
Wexner SD, Rothenberger DA, Jensen L, Goldberg SM, Balcos EG, Belliveau P, Bennett BH, Buls JG, Cohen JM, Kennedy HL, Medwell SJ, Ross TM, Schoetz DJ, Smith LE, Thorson AG. Ileal pouch vaginal fistulas: Incidence, etiology, and management Diseases of the Colon &Amp; Rectum. 32: 460-465. PMID 2676425 DOI: 10.1007/BF02554497 |
0.023 |
|
| 2013 |
Scott HS, Ross TM, Chilton NF, Gass IA, Moubaraki B, Chastanet G, Paradis N, Lètard JF, Vignesh KR, Rajaraman G, Batten SR, Murray KS. Crown-linked dipyridylamino-triazine ligands and their spin-crossover iron(II) derivatives: magnetism, photomagnetism and cooperativity. Dalton Transactions (Cambridge, England : 2003). 42: 16494-509. PMID 23942475 DOI: 10.1039/C3Dt51839F |
0.021 |
|
| 1997 |
Dolle RE, Prasad CV, Prouty CP, Salvino JM, Awad MM, Schmidt SJ, Hoyer D, Ross TM, Graybill TL, Speier GJ, Uhl J, Miller BE, Helaszek CT, Ator MA. Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor. Journal of Medicinal Chemistry. 40: 1941-6. PMID 9207934 DOI: 10.1021/Jm9701637 |
0.019 |
|
| 2009 |
Hanson LR, Liu XF, Ross TM, Doppler E, Zimmermann-Meinzingen S, Moessler H, Frey II WH. Cerebrolysin Reduces Infarct Volume in a Rat Model of Focal Cerebral Ischemic Damage American Journal of Neuroprotection and Neuroregeneration. 1: 60-66. DOI: 10.1166/ajnn.2009.1010 |
0.018 |
|
| 2011 |
Ross TM, Moubaraki B, Wallwork KS, Batten SR, Murray KS. A temperature-dependent order-disorder and crystallographic phase transition in a 0D Fe(II) spin crossover compound and its non-spin crossover Co(II) isomorph. Dalton Transactions (Cambridge, England : 2003). 40: 10147-55. PMID 21894333 DOI: 10.1039/c1dt10961h |
0.018 |
|
| 2012 |
Scott HS, Ross TM, Batten SR, Gass IA, Moubaraki B, Neville SM, Murray KS. Iron(II) mononuclear materials containing functionalised dipyridylamino-substituted triazine ligands: Structure, magnetism and spin crossover Australian Journal of Chemistry. 65: 874-882. DOI: 10.1071/Ch12052 |
0.017 |
|
| 2022 |
Doolan D, Lu S, Ross T, Cox M. Meet the fellows: Everything about ISV. Human Vaccines & Immunotherapeutics. 18: 2096964. PMID 35852928 DOI: 10.1080/21645515.2022.2096964 |
0.017 |
|
| 2011 |
Ross TM, Moubaraki B, Turner DR, Halder GJ, Chastanet G, Neville SM, Cashion JD, Létard JF, Batten SR, Murray KS. Spin crossover and solvate effects in 1D FeII chain compounds containing bis(dipyridylamine)-linked triazine ligands European Journal of Inorganic Chemistry. 1395-1417. DOI: 10.1002/Ejic.201000876 |
0.017 |
|
| 1996 |
Dolle RE, Prouty CP, Prasad CVC, Cook E, Saha A, Ross TM, Salvino JM, Helaszek CT, Ator MA. First examples of peptidomimetic inhibitors of interleukin-1β converting enzyme Journal of Medicinal Chemistry. 39: 2438-2440. PMID 8691439 DOI: 10.1021/Jm9601516 |
0.016 |
|
| 2010 |
Ross TM, Neville SM, Innes DS, Turner DR, Moubaraki B, Murray KS. Spin crossover in iron(III) Schiff-base 1-D chain complexes. Dalton Transactions (Cambridge, England : 2003). 149-59. PMID 20023945 DOI: 10.1039/B913234A |
0.015 |
|
| 1997 |
Wexner SD, Rosen L, Lowry A, Roberts PL, Burnstein M, Hicks T, Kerner B, Oliver GC, Robertson HD, Robertson WG, Ross TM, Senatore P.J. J, Simmang C, Smith C, Vernava AM, et al. Practice parameters for the treatment of mucosal ulcerative colitis - Supporting documentation Diseases of the Colon and Rectum. 40: 1277-1285. PMID 9369100 DOI: 10.1007/BF02050809 |
0.014 |
|
| 2002 |
Parker MH, Chen R, Conway KA, Lee DH, Luo C, Boyd RE, Nortey SO, Ross TM, Scott MK, Reitz AB. Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregation. Bioorganic & Medicinal Chemistry. 10: 3565-9. PMID 12213471 DOI: 10.1016/S0968-0896(02)00251-1 |
0.014 |
|
| 2012 |
Ross TM, Moubaraki B, Neville SM, Batten SR, Murray KS. Polymorphism and spin crossover in mononuclear Fe(II) species containing new dipyridylamino-substituted s-triazine ligands. Dalton Transactions (Cambridge, England : 2003). 41: 1512-23. PMID 22143200 DOI: 10.1039/c1dt11597a |
0.014 |
|
| 1996 |
Steinberg JL, Trudeau ME, Ryder DE, Fishell E, Chapman JA, McCready DR, Fish EB, Hiraki GY, Ross TM, Lickley LA. Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 39: 302-11. PMID 8697321 |
0.01 |
|
| 2015 |
Scott HS, Ross TM, Phonsri W, Moubaraki B, Chastanet G, Létard JF, Batten SR, Murray KS. Discrete FeII Spin-Crossover Complexes of 2,2′-Dipyridylamino-Substituted s-Triazine Ligands with Phenoxo, Cyanophenoxo and Dibenzylamino Functionalities European Journal of Inorganic Chemistry. DOI: 10.1002/ejic.201402972 |
0.01 |
|
| 2010 |
Chesman ASR, Turner DR, Ross TM, Neville SM, Lu J, Murray KS, Batten SR. Chains, helices, sheets and unusual 3D nets: Diverse structures of the flexible, ditopic ligand 1,2-bis(3-(4-pyridyl)pyrazolyl)ethane Polyhedron. 29: 2-9. DOI: 10.1016/J.Poly.2009.05.029 |
0.01 |
|
| 2009 |
Sodora DL, Ross TM. Editorial Current Hiv Research. 7: 1. DOI: 10.2174/157016209787048555 |
0.01 |
|
| 2000 |
Ross TM, Jetter MC, McDonnell ME, Boyd RE, Connelly CD, Martinez RP, Lewis MA, Codd EE, Raffa RB, Reitz AB. α2 Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydrothianaphtheneas a high-affinity ligand for the α(2D) adrenergic receptor [1] Journal of Medicinal Chemistry. 43: 765-768. PMID 10715142 DOI: 10.1021/jm990569e |
0.01 |
|
| 1999 |
Gump FE, Chapman JAW, Miller NA, Lickley HLA, Hanna WM, McCready DR, Link MA, Fishell E, Wright B, Hiraki GY, Ross TM, Fish EB. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast [1] Annals of Surgical Oncology. 6: 510-511. PMID 10458692 DOI: 10.1007/s10434-999-0510-9 |
0.01 |
|
| 1996 |
Wexner SD, Rosen L, Roberts PL, Lowry A, Burnstein M, Hicks T, Kerner B, Oliver GC, Robertson HD, Robertson WG, Ross TM, Senatore P.J. J, Simmang C, Vernava AMI, Wong WD. Practice parameters for treatment of fistula-in-ano - Supporting documentation Diseases of the Colon and Rectum. 39: 1361-1372. PMID 8969661 |
0.01 |
|
| 1992 |
McCready DR, Fish EB, Hiraki GY, Ross TM, Wall JL, Lickley HLA. Total mastectomy is not always mandatory for the treatment of recurrent breast cancer after lumpectomy alone Canadian Journal of Surgery. 35: 485-488. PMID 1393861 |
0.01 |
|
| Hide low-probability matches. |